Mpox vaccine (2024)

A contract for a vaccine indicated for primary vaccination against smallpox, Mpox and disease caused by vaccinia virus in adults. Delivery of more than 150,000 doses will be required over the initial term, with an option to extend for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.